Description
HEMATOLOGY CPRR
First action · last action
2017-11-16 · 2026-03-06
Transactions
35
First transaction's obligation
$688,500
Base + all options value (sum of deltas)
$3,747,763
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
3
SDVOSB flag on record
No
Parent IDV
V797D70260
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 35 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-11-16+$688,500= $688,500
- Mod P000012018-07-09+$0= $688,500
- Mod P000022018-10-30+$20,687= $709,187
- Mod P000032019-09-12+$0= $709,187
- Mod P000042019-09-16+$507,547= $1,216,734
- Mod P000052020-09-02-$205,350= $1,011,384
- Mod P000062020-09-04+$508,551= $1,519,936
- Mod P000072021-05-05-$62,771= $1,457,164
- Mod P000082021-09-10+$424,552= $1,881,716
- Mod P000092022-01-12-$11,792= $1,869,924
- Mod P000102022-01-21-$12,105= $1,857,819
- Mod P000112022-01-21-$14,874= $1,842,945
- Mod P000122022-01-25-$22,511= $1,820,435
- Mod P000132022-09-09+$519,551= $2,339,986
- Mod P000142022-11-04-$22,167= $2,317,819
- Mod P000152023-01-30-$9,521= $2,308,298
- Mod P000162023-04-14-$12,333= $2,295,965
- Mod P000172023-07-07-$16,249= $2,279,716
- Mod P000182023-09-15+$254,772= $2,534,489
- Mod P000192024-03-08-$12,637= $2,521,852
- Mod P000202024-04-23-$22,337= $2,499,516
- Mod P000212024-06-03-$20,915= $2,478,601
- Mod P000222024-06-12+$94,554= $2,573,155
- Mod P000242024-06-22-$5,164= $2,567,992
- Mod P000252024-07-03-$1,418= $2,566,574
- Mod P000262024-07-09-$2,033= $2,564,541
- Mod P000232024-08-12-$9,534= $2,555,007
- Mod P000272024-08-13-$4,806= $2,550,201
- Mod P000282024-08-13-$30,796= $2,519,405
- Mod P000292024-09-18+$55,806= $2,575,211
- Mod P000302024-10-10-$8,757= $2,566,454
- Mod P000312025-05-15+$8,532= $2,574,986
- Mod P000322025-10-22-$2,706= $2,572,280
- Mod P000332026-01-20-$3,856= $2,568,424
- Mod P000342026-03-06-$6,971= $2,561,453
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-11-16 | +$688,500 | $688,500 | HEMATOLOGY CPRR |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2018-07-09 | +$0 | $688,500 | HEMATOLOGY CPRR |
| Mod P00002· CHANGE ORDER | 2018-10-30 | +$20,687 | $709,187 | HEMATOLOGY CPRR |
| Mod P00003· FUNDING ONLY ACTION | 2019-09-12 | +$0 | $709,187 | HEMATOLOGY CPRR |
| Mod P00004· EXERCISE AN OPTION | 2019-09-16 | +$507,547 | $1,216,734 | HEMATOLOGY CPRR |
| Mod P00005· FUNDING ONLY ACTION | 2020-09-02 | −$205,350 | $1,011,384 | HEMATOLOGY CPRR |
| Mod P00006· EXERCISE AN OPTION | 2020-09-04 | +$508,551 | $1,519,936 | HEMATOLOGY CPRR |
| Mod P00007· FUNDING ONLY ACTION | 2021-05-05 | −$62,771 | $1,457,164 | HEMATOLOGY CPRR |
| Mod P00008· EXERCISE AN OPTION | 2021-09-10 | +$424,552 | $1,881,716 | HEMATOLOGY CPRR |
| Mod P00009· FUNDING ONLY ACTION | 2022-01-12 | −$11,792 | $1,869,924 | HEMATOLOGY CPRR |
| Mod P00010· FUNDING ONLY ACTION | 2022-01-21 | −$12,105 | $1,857,819 | HEMATOLOGY CPRR |
| Mod P00011· FUNDING ONLY ACTION | 2022-01-21 | −$14,874 | $1,842,945 | HEMATOLOGY CPRR |
| Mod P00012· FUNDING ONLY ACTION | 2022-01-25 | −$22,511 | $1,820,435 | HEMATOLOGY CPRR |
| Mod P00013· EXERCISE AN OPTION | 2022-09-09 | +$519,551 | $2,339,986 | HEMATOLOGY CPRR |
| Mod P00014· FUNDING ONLY ACTION | 2022-11-04 | −$22,167 | $2,317,819 | HEMATOLOGY CPRR |
| Mod P00015· FUNDING ONLY ACTION | 2023-01-30 | −$9,521 | $2,308,298 | HEMATOLOGY CPRR |
| Mod P00016· FUNDING ONLY ACTION | 2023-04-14 | −$12,333 | $2,295,965 | HEMATOLOGY CPRR |
| Mod P00017· FUNDING ONLY ACTION | 2023-07-07 | −$16,249 | $2,279,716 | HEMATOLOGY CPRR |
| Mod P00018· OTHER ADMINISTRATIVE ACTION | 2023-09-15 | +$254,772 | $2,534,489 | HEMATOLOGY CPRR |
| Mod P00019· FUNDING ONLY ACTION | 2024-03-08 | −$12,637 | $2,521,852 | HEMATOLOGY CPRR |
| Mod P00020· FUNDING ONLY ACTION | 2024-04-23 | −$22,337 | $2,499,516 | HEMATOLOGY CPRR |
| Mod P00021· FUNDING ONLY ACTION | 2024-06-03 | −$20,915 | $2,478,601 | HEMATOLOGY CPRR |
| Mod P00022· OTHER ADMINISTRATIVE ACTION | 2024-06-12 | +$94,554 | $2,573,155 | HEMATOLOGY CPRR |
| Mod P00024· FUNDING ONLY ACTION | 2024-06-22 | −$5,164 | $2,567,992 | HEMATOLOGY CPRR |
| Mod P00025· FUNDING ONLY ACTION | 2024-07-03 | −$1,418 | $2,566,574 | HEMATOLOGY CPRR |
| Mod P00026· FUNDING ONLY ACTION | 2024-07-09 | −$2,033 | $2,564,541 | HEMATOLOGY CPRR |
| Mod P00023· FUNDING ONLY ACTION | 2024-08-12 | −$9,534 | $2,555,007 | HEMATOLOGY CPRR |
| Mod P00027· FUNDING ONLY ACTION | 2024-08-13 | −$4,806 | $2,550,201 | HEMATOLOGY CPRR |
| Mod P00028· FUNDING ONLY ACTION | 2024-08-13 | −$30,796 | $2,519,405 | HEMATOLOGY CPRR |
| Mod P00029· FUNDING ONLY ACTION | 2024-09-18 | +$55,806 | $2,575,211 | HEMATOLOGY CPRR |
| Mod P00030· FUNDING ONLY ACTION | 2024-10-10 | −$8,757 | $2,566,454 | HEMATOLOGY CPRR |
| Mod P00031· FUNDING ONLY ACTION | 2025-05-15 | +$8,532 | $2,574,986 | HEMATOLOGY CPRR |
| Mod P00032· OTHER ADMINISTRATIVE ACTION | 2025-10-22 | −$2,706 | $2,572,280 | HEMATOLOGY CPRR |
| Mod P00033· OTHER ADMINISTRATIVE ACTION | 2026-01-20 | −$3,856 | $2,568,424 | HEMATOLOGY CPRR |
| Mod P00034· OTHER ADMINISTRATIVE ACTION | 2026-03-06 | −$6,971 | $2,561,453 | HEMATOLOGY CPRR |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under 6515 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026F0700 | GOVERNMENT MARKETING AND PROCUREMENT, LLC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $369,509 | FY2026 |
| 36C25026P1048 | DELTA INTERNATIONAL SERVICES & LOGISTICS (USA), INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $84,999 | FY2026 |
| 36C25026F0687 | PENTAX OF AMERICA, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $18,292 | FY2026 |
| 36C25026F0670 | A.M. COMMUNICATIONS SOLUTIONS, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $19,087 | FY2026 |
| 36C25026F0680 | OLYMPUS AMERICA INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $381,132 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25018F0491_3600_V797D70260_3600 · retrieved 2026-09-26.